I agree that this site is using cookies. You can find further informations here.
X
Chéramy, Mikael
20  results:
Search for persons X
?
1

Effect of simultaneous vaccination with H1N1 and GAD-alum o..:

Tavira, Beatriz ; Cheramy, Mikael ; Axelsson, Stina...
Diabetologia.  60 (2017)  7 - p. 1276-1283 , 2017
Link: https://doi.org/10.1007/..
 
?
2

GAD-specific T cells are induced by GAD-alum treatment in T..:

Pihl, Mikael ; Barcenilla, Hugo ; Axelsson, Stina...
Clinical Immunology.  176 (2017)  - p. 114-121 , 2017
Link: https://doi.org/10.1016/..
 
?
3

GAD‐treatment of children and adolescents with recent‐onset..:

Ludvigsson, Johnny ; Chéramy, Mikael ; Axelsson, Stina...
Diabetes/Metabolism Research and Reviews.  30 (2014)  5 - p. 405-414 , 2014
Link: https://doi.org/10.1002/..
 
?
4

Cellular and Humoral Immune Responses in Type 1 Diabetic Pa..:

Axelsson, Stina ; Chéramy, Mikael ; Åkerman, Linda...
Diabetes Care.  36 (2013)  11 - p. 3418-3424 , 2013
Link: https://doi.org/10.2337/..
 
?
5

GAD autoantibody epitope pattern after GAD-alum treatment i..:

Skoglund, Camilla ; Chéramy, Mikael ; Casas, Rosaura..
Pediatric Diabetes.  13 (2011)  3 - p. 244-250 , 2011
Link: https://doi.org/10.1111/..
 
?
6

Increased expression of regulatory T cell-associated marker..:

Pihl, Mikael ; Chéramy, Mikael ; Mjösberg, Jenny..
Open Journal of Immunology.  1 (2011)  3 - p. 57-64 , 2011
Link: https://doi.org/10.4236/..
 
?
7

Long-Lasting Immune Responses 4 Years after GAD-Alum Treatm..:

Axelsson, Stina ; Chéramy, Mikael ; Hjorth, Maria...
PLoS ONE.  6 (2011)  12 - p. e29008 , 2011
Link: https://doi.org/10.1371/..
 
?
8

GAD-alum treatment in patients with type 1 diabetes and the..:

Chéramy, Mikael ; Skoglund, Camilla ; Johansson, Ingela...
Clinical Immunology.  137 (2010)  1 - p. 31-40 , 2010
Link: https://doi.org/10.1016/..
 
?
9

Effect of simultaneous vaccination with H1N1 and GAD-alum o..:

Tavira Iglesias, Beatriz ; Chéramy, Mikael ; Axelsson Chéramy, Stina...
Diabetologia, 0012-186X, 2017, 60:7, s. 1276-1283.  , 2017
Link: http://urn.kb.se/resolve..
 
?
10

Regulatory T cell phenotype and function 4 years after GAD–..:

Pihl, Mikael ; Åkerman, Linda ; Axelsson, Stina...
Clinical and Experimental Immunology, 0009-9104, 2013, 172:3, s. 394-402.  , 2013
Link: http://urn.kb.se/resolve..
 
?
11

Characteristics of in-vitro phenotypes of glutamic acid dec..:

Chéramy, Mikael ; Hampe, Christiane S ; Ludvigsson, Johnny.
Clinical and Experimental Immunology, 0009-9104, 2013, 171:3, s. 247-254.  , 2013
Link: http://urn.kb.se/resolve..
 
?
12

Cellular and Humoral Immune Responses in Type 1 Diabetic Pa..:

Axelsson, Stina ; Chéramy, Mikael ; Åkerman, Linda...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
13

Cellular and Humoral Immune responses in Type 1 Diabetic pa..:

Axelsson, Stina ; Cheramy, Mikael ; Åkerman, Linda...
Diabetes Care, 0149-5992, 2013, 36:11, s. 3418-3424.  , 2013
Link: http://urn.kb.se/resolve..
 
?
14

Characteristics of GADA in Type 1 Diabetes following Immuno..:

Chéramy, Mikael
Linköping University Medical Dissertations, 0345-0082.  , 2012
Link: http://urn.kb.se/resolve..
 
?
15

Extended evaluation of the safety and efficacy of GAD treat..:

Ludvigsson, Johnny ; Hjorth, Maria ; Chéramy, Mikael...
DIABETOLOGIA, 0012-186X, 2011, 54:3, s. 634-640.  , 2011
Link: http://urn.kb.se/resolve..
 
1-15